Cancer Genetics Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare. Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk The health system will partner with the NCI to look for new cancer risk variants in a large population biobank, in the hopes of improving screening and care. Cancer Genetics to Sell $17.5M in Common Stock Through Direct Offering The New Jersey-based cancer drug-discovery services provider said it had signed agreements to sell the shares to unnamed institutional investors. Cancer Genetics to Raise $10M in Private Placement The firm plans to use the net proceeds for general corporate purposes, including working capital and capital expenditures. Cancer Genetics Q3 Revenues Down 24 Percent The drug discovery and preclinical oncology services provider attributed the revenue decline to the impact of the SARS-CoV-2 pandemic on its customers. Aug 24, 2020 Cancer Genetics to Acquire Organoid Startup Stemonix Aug 14, 2020 Cancer Genetics Q2 Revenues Drop 5 Percent Jun 25, 2020 Cancer Genetics Q1 Revenues Drop 22 Percent Jun 1, 2020 Cancer Genetics Q4 2019 Revenues Up 12 Percent Nov 20, 2019 Cancer Genetics' Discovery Services Drive Q3 Revenue Gains Nov 13, 2019 Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences Oct 25, 2019 Cancer Genetics Settles Failed Merger Deal With NovellusDx; Receives $6M From Interpace Oct 24, 2019 Cancer Genetics Announces 1-for-30 Reverse Stock Split Aug 20, 2019 Cancer Genetics Posts 15 Percent Rise in Q2 Revenues Jul 16, 2019 Parkinson's Foundation, Fulgent Genetics Partner on Genetic Testing Initiative Jul 15, 2019 Interpace Dx Acquires Cancer Genetics' Biopharma Services May 21, 2019 Cancer Genetics Q1 Revenues Fall 11 Percent Apr 16, 2019 Cancer Genetics Q4 Revenues Down 9 Percent Jan 11, 2019 People in the News: Cindy Perettie, William Finger, Richard Compton, More Jan 10, 2019 Cancer Genetics Targets $3M in Public Offering Dec 17, 2018 Cancer Genetics Cancels Planned Merger With NovellusDx Nov 20, 2018 Cancer Genetics Q3 Revenues Fall 26 Percent Nov 16, 2018 People in the News: Glenn Miles, Roy Smythe, Steve Ziganti, More Oct 18, 2018 Cancer Genetics, GeneCast Ink Cancer Test Distribution Deal Oct 8, 2018 Cancer Genetics, Cellaria Collaborate on Precision Oncology Tools Load More Breaking News GenXys, Helix Partner to Provide Clinical Decision Support for PGx Testing Persephone Biosciences, Janssen Biotech Ink Biomarker Discovery Agreement Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy PhenoTips Raises C$2.5M in Seed Funding Fauna Bio Raises $9M in Seed Money Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test The Scan Two J&J Doses Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports. Pfizer-BioNTech Vaccine Response in Kids The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post. Chicken Changes to Prevent Disease The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics. PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.